EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and TreatmentJocelyn Reader(University of Maryland, Baltimore), Dana M. Roque(Gynecologic Oncology Group)CancersOctober 18, 201910.3390/cancers11101590Cited by 17SaveCiteExport RISWatch citationsRelated PapersMalignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response|Cancers|2021|151